Long-time executive Adam Townsend steps into CEO role, signaling a new era of innovation and operational excellence at InfoMart, a leader in the background screening industry.

Comedy Village Times Square is thrilled to announce that trailblazing comedian and producer Carole Montgomery is bringing her hit show, FUNNY WOMEN OF A CERTAIN AGE®, to the club for a brand-new ...

Lionheart Health, Inc., an Orange County, California- based biotechnology company, has been named one of the 40 semi-finalists advancing in the $101M XPRIZE Healthspan Competition at the Longevity ...

Afrisource, a new nonprofit founded by two BYU–Idaho alumni, is redefining outsourcing by connecting global companies with vetted African professionals. With a mission to drive economic mobility, this ...

RChilli is pleased to announce its participation in Ascend 2025, from June 8–11, 2025, at Rosen Shingle Creek, Orlando, Florida. The RChilli team will be available at booth #522, presenting their ...

HeartBeam, a medical technology company, has achieved significant progress in developing innovative cardiac monitoring solutions, including successful FDA study completion, strategic partnerships, and ...

NanoViricides is developing a breakthrough antiviral treatment, NV-387, targeting Measles and MPox in response to rising global case counts and existing vaccine limitations. The company's strategic ...

Knightscope demonstrates significant financial improvement in Q1 2025, with 29% revenue growth and reduced net losses, positioning the company for potential expansion in the public safety technology ...

Tonix Pharmaceuticals has strategically enhanced its executive leadership by appointing Joseph Hand as General Counsel and Executive Vice President of Operations. Hand's extensive corporate experience ...

Canadian sustainable Bitcoin mining company POW.RE plans to acquire Swiss financial services firm Block Green, creating a comprehensive Bitcoin credit infrastructure platform with enhanced market ...

CNS Pharmaceuticals has completed a public offering raising $5 million, providing crucial funding for its ongoing research into brain and central nervous system cancer treatments, with a focus on its ...

Glucotrack's groundbreaking continuous blood glucose monitoring device successfully completed its first human study, demonstrating potential for more accurate and less invasive diabetes management.